Richard Hain

نویسنده

  • MAKOTO MATSUMOTO
چکیده

Suppose that r and n are non-negative integers satisfying r + n > 0. Denote the moduli stack over SpecZ of smooth elliptic curves with n marked points and r non-zero tangent vectors by M1,n+r⃗. Here the n marked points and the anchor points of the r tangent vectors are distinct. Taking each tangent vector to its anchor point defines a morphism M1,n+r⃗ → M1,n+r that is a principal Gm-bundle. The Deligne-Mumford compactification [8] of M1,n will be denoted by M1,n. It is also defined over SpecZ. In this paper, we are primarily concerned with the cases (n, r) = (1, 0), (0, 1) and (2, 0). For a Z-algebra A, we denote by M1,n+r⃗/A the stack M1,n+r⃗ ×SpecZ SpecA. Similarly, the pullback of M1,n to SpecA will be denoted by M1,n/A. The universal elliptic curve over M1,1 will be denoted by E . Note that M1,2 is E with its identity section removed. The extension E → M1,1 of the universal elliptic curve to M1,1 is obtained by1 glueing in the Tate curve ETate → SpecZ[[q]] (cf. [41, Ch. V]). It is simply M1,2. The unique cusp of M1,1 is the moduli point of the nodal cubic. Denote it by eo. The standard line bundle L over M1,1 is the conormal bundle of the zero section of E → M1,1. Sections of L⊗n over M1,1 are modular forms of weight n, and those that vanish at the cusp eo are cusp forms of weight n. The restriction of the relative tangent bundle of E to its identity section is the dual Ľ of L. The moduli space M1,⃗1 is Ľ′, the restriction of Ľ to M1,1 with its zero-section removed. This is isomorphic to the complement L′ of the zero-section of L. We will also identify M1,1 with the identity section of E . With this convention, eo also denotes the identity of the nodal cubic in E and also the corresponding point of the partial compactification Ľ of M1,⃗1. An explicit description of L′ over M1,1 can be deduced from the discussion [28, Chapt. 2] and the formulas in [40, Appendix A]. Then M1,1 is the quotient stack Gm\\L. When 2 and 3 are invertible in A, LA is the scheme LA = AA − {0} = SpecA[u, v]− {0}. The point (u, v) corresponds to the plane cubic y = 4x − ux− v and the abelian differential dx/y. The Gm-action is λ : (u, v) 7→ (λ−4u, λ−6v). In this case, M1,1 and M1,1 are the quotient stacks M1,1/A = Gm\\LA and M1,1/A = Gm\\(AA −D−1(0)), where D = u − 27v is (up to a factor of 4) the discriminant of the cubic. Similarly, when 2 and 3 are invertible in A, M1,2/A is the quotient of the scheme {(u, v, x, y) ∈ AA × AA : y = 4x − ux− v, (u, v) ̸= 0}

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance

Less than 30% of multidrug-resistant tuberculosis (MDR-TB) patients are currently diagnosed, due to laboratory constraints. Molecular diagnostics enable rapid and simplified diagnosis. Newer-version line probe assays have not been evaluated against the WHO-endorsed Hain GenoType MTBDRplus (referred to as Hain version 1 [V1]) for the rapid detection of rifampin (RIF) and isoniazid (INH) resistan...

متن کامل

Intensive Care: Because you’re worth it?

documentary called 23 Week Babies: the Price of Life. My thoughts and feelings as I watched this programme were not always straightforward. The documentary was moving, sometimes profoundly so. How could it avoid emotional impact when it dealt with life and death, compassion and vulnerability, hope and loss? There were other times when I found myself irritated and frustrated with the presenter a...

متن کامل

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study

INTRODUCTION Despite recent diagnostic advances, the majority of multidrug-resistant tuberculosis (MDR-TB) cases remain undiagnosed. Line probes assays (LiPAs) hold great promise to curb the spread of MDR-TB as they can rapidly detect MDR-TB even when laboratory infrastructure is limited, yet few of these assays are currently widely available or supported by World Health Organization (WHO) poli...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014